Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Projected Market Size Of The Colorectal Cancer Molecular Diagnostics Market By 2029?
The colorectal cancer molecular diagnostics market has experienced robust growth in recent years. This market is projected to expand from $2.56 billion in 2024 to $2.76 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 7.9%. Historically, this expansion has been driven by factors such as the rising incidence of colorectal cancer, enhanced awareness and screening programs, a growing focus on personalized medicine, and various government initiatives aimed at cancer control.
The colorectal cancer molecular diagnostics market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $3.79 billion by 2029, achieving a compound annual growth rate (CAGR) of 8.3%. This projected growth during the forecast period is primarily driven by factors such as an aging population and escalating risk factors, the increasing incorporation of genomic data into clinical settings, the proliferation of precision medicine strategies, and worldwide endeavors in cancer research and collaborative initiatives. Key trends expected during the forecast period encompass a heightened focus on biomarkers for early detection, the incorporation of artificial intelligence (AI) in data analysis, the growing prevalence of circulating tumor DNA (CTDNA) analysis, the broader development of companion diagnostics supporting targeted therapies, and an intensified concentration on immunotherapy biomarkers.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13120&type=smp
What Are The Main Drivers Boosting The Colorectal Cancer Molecular Diagnostics Industry’s Expansion?
The rising occurrence of inflammatory bowel diseases (IBD) is projected to boost the expansion of the colorectal cancer molecular diagnostic market. IBD refers to chronic digestive system conditions marked by inflammation of the digestive tract, mainly affecting the colon and rectum, presenting symptoms such as abdominal pain, diarrhea, and weight loss, managed via medications, lifestyle adjustments, and occasionally surgery. This escalating prevalence of IBD heightens the need for precise, effective, and sophisticated diagnostic tools, which are crucial since decisions regarding systemic therapy for colorectal cancer (CRC) are largely based on tumor molecular assessment outcomes. For example, in April 2024, the UK Parliament, a UK-based Governing body, noted that 2022 research by Crohn’s & Colitis UK indicated 500,000 individuals in the UK suffer from Inflammatory Bowel Disease (IBD), almost twice the prior estimations. Consequently, the growing incidence of inflammatory bowel diseases (IBD) will propel the growth of the colorectal cancer molecular diagnostic market.
How Is The Colorectal Cancer Molecular Diagnostics Market Segmented?
The colorectal cancer molecular diagnosticsmarket covered in this report is segmented –
1) By Type: Instruments; Reagents And Kits; Services
2) By Technology: Polymerase Chain Reaction (PCR); Sequencing; Mass Spectrometry; Transcription Mediated Amplification; Chips And Microarrays; Isothermal Nucleic Acid Amplification Technology (INAAT)
3) By End Users: Hospitals; Ambulatory Surgical Centers; Diagnostic Laboratories; Homecare Settings
Subsegments:
1) By Instruments: PCR Machines; Sequencers; Microarrays
2) By Reagents And Kits: DNA Or RNA Extraction Kits; Assay Kits; Reagent Packs
3) By Services: Diagnostic Testing Services; Genetic Testing Services; Consultation Services
How Are Trends Influencing The Colorectal Cancer Molecular Diagnostics Market?
Companies operating in the colorectal cancer molecular diagnostic market are prioritizing the development of innovative molecular diagnostics and personalized medicine solutions, such as the Shield Blood Test approach, to identify colorectal cancer at an earlier, more treatable stage. The Shield Blood Test is an initial blood test designed to detect early-stage colorectal cancer (CRC). For example, in May 2022, Guardant Health, a US-based biotechnology company providing oncology molecular diagnostic products, launched its Shield Blood Test. This particular shield test offers a convenient screening method involving a simple blood draw to address challenges related to patients’ willingness to undergo screening. The test exhibited a sensitivity of 91% for detecting colorectal cancer and 20% for identifying advanced adenomas, while its specificity was measured at 92%. The Shield test identifies early colorectal cancer signals in the blood by utilizing data from diverse cohorts of over 2,000 subjects with colorectal cancer, 357 with advanced adenoma, and 3,757 normal subjects.
Which Major Firms Are Strengthening Their Position In The Colorectal Cancer Molecular Diagnostics Industry?
Major companies operating in the colorectal cancer molecular diagnostics market report are Johnson & Johnson, Bayer AG, Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Biocartis Group NV, Agilent Technologies Inc., Grifols S.A, Hologic Inc., Biomérieux SA, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corporation, Illumina Inc., Cepheid, Myriad Genetics Inc., Guardant Health, Luminex Corporation, GenMark Diagnostics, Amoy Diagnostics Co. Ltd., MDxHealth Inc., HTG Molecular Diagnostics Inc., GenPath Diagnostics, geneOmbio Technologies Pvt.
Download The Full Report For Exclusive Market Findings:
Which Geographies Are Emerging As Strong Markets For The Colorectal Cancer Molecular Diagnostics Industry?
North America was the largest region in the colorectal cancer molecular diagnostics market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the colorectal cancer molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Colorectal Cancer Molecular Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/customise?id=13120&type=smp
Browse Through More Reports Similar to the Global Colorectal Cancer Molecular Diagnostics Market 2025, By The Business Research Company
Small Cell Lung Cancer Therapeutics Global Market Report 2025
Urinary Tract Cancer Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/urinary-tract-cancer-global-market-report
Blockchain Services Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/blockchain-services-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model